Author/Authors :
Hassa، Hikmet نويسنده Department of Obstetrics and Gynecology, Reproductive Medicine Unit, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey , , Aydin، Yunus نويسنده Department of Obstetrics and Gynecology, Reproductive Medicine Unit, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey , , Yavuz Tokgoz، Vehbi نويسنده Department of Obstetrics and Gynecology, Reproductive Medicine Unit, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey ,
Abstract :
We presented a cerebral venous thrombosis case associated with lack of proper medical
evaluation required for confirmation of suppression and exclusion of current
pregnancy before starting assisted reproductive technology (ART) cycle. This is
a case-report study about a 37-year-old woman who presented to emergency room
with abdominal pain and tenderness. Initial human chorionic gonadotropin (hCG)
value was 17616 IU/L. Endometrium was heteregenous and incompatible with a
normal intrauterine pregnancy. She had a history of antagonist protocol/controlled
ovarian hyperstimulation (COH) started 38 days ago in a different in vitro fertilization
(IVF) center. Because of the fertilization failure, she had no embryo transfer.
With ectopic pregnancy diagnosis, we made surgical exploration and observed a
material which was consistent with ectopic pregnancy on the right tuba uterina.
Partial salpingectomy was applied because of actively bleeding ectopic pregnancy.
Two days after discharging from hospital; she presented to emergency room again
with syncope and generalized tonic-clonic seizure. By cranial tomography generalized
edema, cerebral venous thrombosis was established. Enoxaparine sodium 0.6
ml twice daily was administered. Six days after hospitalisation, she was discharged
with normal neurological examination under phenytoin 200 mg daily and enoxaparine
sodium 0.6 ml daily. Before ART treatment, clinicians must always rule out
the likelihood of existing pregnancy by measuring estradiol, follicle stimulating
hormone (FSH), and luteinizing hormone (LH). On the other hand, low-molecularweight
heparine may be effective in cerebral venous thrombosis treatment. Therefore,
intracerebral thrombosis is one of the rare mortal complications of ART.